Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let me also say I have added to my position all month and will continue to add. The fear is of us becoming bankrupt, I know Dr Moro could have easily sold this technology and parted a rich man, but he will see this thru. Good luck and I will gladly continue buying your shares.
ISOBM. I'll see everyone at the finish line. This board is of no use to anyone recently, so I'm out of here.
Kag, what rude awakening? We are presenting in September, our results are better than ever (new tests to confirm) and IMO, I have a suspicion everyone's dire attitude will change shortly. I said my peace and I'll leave it at that.
In this market environment there are no free passes. All of the speculators have left this stock and we are down to the true believers. Dr Moro needs to get Recaf in the hands of these institutions listed today in US News
http://www.usnews.com/directories/hospitals/index_html/specialty+ihqcanc
Dr Moro, I hope you are on the phone as I am writing this.
Recaf is now patented so there are no more excuses. Get a form letter out today with an open invitation to experiment with Recaf.
I would never make up such a thing, but I am frustrated it won't open and I looked on SEC filings and don't see it either. I am truthful, and have no idea what is in the filing or if it is an old one, but it came up today at 10:39 AM 6-24-2008. Can't open and won't cut and paste. Sorry, I'm just as curious as everyone and hope someone can figure this out.
Today. It won't open. It showed up on Schwab.
Something is brewing. They just filed a CT ORDER with SEC. Means confidential terms, so we are closer to a deal with someone than every thinks.
Joe. I did a link to it or go to Biocurex website and click on investors and it should go directly to it. You must be missing a program which you can download to open it. It might be Adobe Acrobat.
http://www.biocurex.com/pages/PowerPoint.swf
I see you guys are clicking on the down arrow. Click the #1 right arrow and continue clicking on the right arrow to see the pages.
IMO, as long as Dr Moro continues to deliver (and I have no reason to have doubts) I am looking forward to our next press release. I like the tone at which Dr Moro is presently speaking. He is now deliberate in what he is saying and appears very confident. I have done more than my share of due diligence and have no worries only anticipation.
I really like that powerpoint presentation. I will suggest to manangement that every future press release have a link to that presentation so it will enlighten new investors to what we lay claim to and fully stand behind.
http://www.biocurex.com/pages/PowerPoint.swf
They totally bash the PSA. No wonder Abbott is pi**ed.
They came when the stock was halted not while Terry was there, but he said they did physically come to the lab.
Gold, it was in a conversation with Terry awhile back. He was reassuring me that everything was on the "up and up". That was at a time when I was unsure of the legitimacy of the whole operation. As a matter of fact also the scientists from Biosite were also visitors before the deal was consumated and came then came back.
These are some bold statements on our website and after the SEC physically came to the Biocurex facilities Dr Moro stands behind his claims and with our scientific board clearly backing us up I would like everyone to look at this powerpoint presentation and tell me how they feel about the future of our company.
http://www.biocurex.com/pages/PowerPoint.swf
Everyone please stay focused on the big picture and IMO your patience will be rewarded. I just reread this and it helps me to remember why I remain convicted to Biocurex. Good luck to all longs.
Also look at the page that lists only 3 major diagnostic companies that use automated instruments...Abbott, Bayer, Roche. They are obviously focused on these three.
I may seem biased, but I have a tendency to reread the press releases slowly several times and decipher what direction the company is going. We all know that Dr Moro is restricted from saying certain things due to licensing agreements and the SEC, but like I informed the I-hub readers, I have recently added to my position and IMO am feeling confident that Dr Moro will succeed. I have learned many interesting things from the contributions from this board, and in my quest for information about our company I have learned alot about the science and our competition. I am content with our progress, and my confidence was raised when Dr Moro developed the ELISA test. You can almost sense how giddy he is with that last press release. IMO it is the share price that is the remaining barrier. Once the share price gets out of this funk it will be a fast ride to the top. The final question for me is why is the share price so low? I guarantee management is wondering the same thing. Anyone have an answer to this? We seem to be in concensus about the technology, and we are all excited about the newest test, so why not an increase in volume and pps?
These tests strictly are yes or no. In simple terms, it is exactly like a pregnancy test. In the near future Recaf will be important once an individual has genetic testing and finds that he or she is predisposed to cancer. Unfortunately, the genetic test will be unable to say which type of cancer and that is where a universal marker (Recaf) will become even more important in early detection.
Stay focused: Previous post but still relevant
A Few Reasons to Own BOCX:
1.. BOCX has patented and proprietary technology that is leading the way in early cancer detection.
2.. BOCX is currently developing and commercializing cancer diagnostic products based upon their breakthrough RECAFTM cancer marker technology.
3.. A vaccine based on BOCX's proprietary RECAFTM technology that would protect against most types of cancer has a $2B market potential in U.S. alone.
4.. Radioisotope imaging of RECAFTM positive cancer cells can be obtained with standard hospital equipment. Projected as a $1B U.S. market share for BOCX.
5.. $ 2 Billion Dollar market targeted for BOCX's single serum test for the diagnosis of numerous types of cancer. To be launched under the name Serum-RECAFTM.
6.. $3 Billion Dollar market share is seen as realistic as BOCX joins the Antibody Therapy arena with very favorable results from preliminary studies based on BOCX's RECAFTM technology.
7.. BOCX targets growing market for minimizing or eliminating side effects of cancer chemotherapy, utilizing its RECAFTM antibodies for drug and radioisotope delivery.
8.. BOCX is seen as a prime-licensing candidate based on the multitude of clinical uses of BOCX's proprietary RECAF TMtechnology.
9.. BOCX has assembled a team of renowned individual scientists and experts under the direction of Dr. Phillip Gold, the most eminent investigator in the cancer marker field.
10.. Investigators at BOCX have demonstrated that leukemia can be diagnosed and monitored utilizing BOCX's RECAFTM staining technology. By cleansing patients' bone marrow of cancer cells, need for bone marrow transplants might be eliminated.
11.. BOCX's Histo-RECAFTM, a special cancer detection kit for tissues, has been cleared for sale by the FDA for U.S. markets, with an early projected market potential of $200 million.
12.. Histo-RECAFTM HAS BEEN CLEARED BY THE FDA FOR SALE IN THE USA.
ABOUT BOCX
BOCX is biotechnology company dedicated to the development of innovative healthcare solutions for the new millennium. The first of these groundbreaking new technologies is in the field of cancer diagnosis, tumor imaging, and treatment. The technology identifies a widespread cancer biomarker known as RECAFTM, which enables the potential for detection of the vast majority of malignant cancers from blood tests, tissue biopsies or other specimen types.
Put simply, RECAFTM is the only biomarker known to be present in most types of cancer cells and BOCX's patented technology is the only means to detect it. What's more, RECAFTM technology distinguishes cancer cells from normal cells and malignant tumors from benign tumors.
Research indicates RECAFTM is present in practically 100% of breast cancers and in approximately 90% of cancers overall. The technology may also be applied to pinpoint the exact location of a cancer in the body using imaging technology. It is anticipated that RECAFTM will replace certain other biomarkers that may only detect one type of cancer or are not sensitive or specific to a particular malignancy. Its widespread nature indicates that RECAFTM technology may be applied to cancers for which there are no other effective markers - particularly breast and lung cancers, which together represent one third of all cancers.
In addition to the USA, BOCX has patents pending for RECAFTM in more than 20 countries and has already received patents in Australia and Russia.
Investment Opportunity
BACKGROUND
In North America, there are over 8 million cancer patients and approximately 1 million new cases are reported each year. Over 1/3 of the population will develop cancer at some point during their life and over one-half million people die from cancer each year. The new incidences of cancer along with the maintenance of persons living with cancer will continue to increase the demand for cancer products. The present world market for cancer therapeutics is approximately US$12 billion per year. The National Cancer Institute estimates overall annual costs for cancer in the U.S. at US$104 billion with US$35 billion in direct medical costs and the remainder in productivity and mortality-related costs. Approximately 1/2 of the direct costs are related to the treatment of breast, lung and prostate cancers.
TECHNOLOGY
A novel widespread cancer marker named RECAFTM. Cancer markers' are molecules that appear on cancer cells but not on normal cells and finding new ones is one of the most important goals in cancer research (only half a dozen have been found in the past 40 years). PSA (prostate cancer) and CEA (colorectal cancer) are well known cancer markers. They can by used to detect (diagnose) and then specifically target cancer cells (therapy) -- offering the potential to provide treatment of cancer by delivering antibodies, drugs and radiation to the targeted cancerous cells.
PRODUCTS
Histo-RECAFTM HAS BEEN CLEARED BY THE FDA FOR SALE IN THE USA.
Its sister product, Cryo RECAFTM - for use for diagnosis on frozen sections while the patient is under anesthesia - is fully developed and awaiting further testing prior to FDA submission. BOCX is actively working on the serum test, which will be launched under the name Serum- RECAFTM.
MARKET POTENTIAL IN THE USA ALONE
Pathology $200M
Blood tests $2B
Imaging $1B
Antibody therapy $3B
RECAF Vaccine $2B
Wow. There are alot of big egos on this board. There was a time that we all banned together and realized this wasn't any ordinary stock investment. This truly is an all or none deal. Dissecting each other's comments is nonproductive and I have based alot of my previous decisions (because of a lack of shareholder information by management) on some serious open-minded discussions on this board. I can only remind everyone once again that Dr Moro will present this new data at the upcoming meeting. As long as the results continue at this level I see great potential and I repeat he will garner more data INDEPENDENTLY. I would be out of my mind not to say that the recent share price doesn't hurt, but I could give countless examples of stocks reacting irrationally (Imclone, for one) only to return from the ashes and become great companies. For some investors, I can't blame them for getting impatient. It is emotional. I liked what I saw Recaf could do 4 years ago and I especially like what I see today. Please don't pick apart what I say. I am speaking from my perspective. I like meaningful discussions and we have had many. We all have the right to ask questions, but when we don't get the answers we want to hear don't judge that person. Take what everyone, including myself has to say with a grain of salt. Now let's all shake hands and make up. Everyone.......have a great weekend!
My focus is solely on sensitivity and specificity. How soon we forget that there presently are no markers for lung, breast,stomach, ovarian, bladder, kidney, liver, and what markers we presently do have are not nearly as accurate as Recaf, so you all can debate all you want whether this is happening or who said what to whom, but my money is on Recaf and it will remain as long as we continue to get consistent stellar results. That is the one thing you don't have to speculate on and that is why I will continue to support this company. I don't have rose colored glasses on. My opinion is based soley on data that has and will continue to blow away what present medicine has to offer, and yes I have yesterday and today added to my position.
I appreciate everyone's perspective with few exceptions (Zolax). When I have been upset in the past I didn't hold back, but I think we really have turned the corner. I can actually see the finish line. I apologize if I seem as if I am overexcited, but I see us as a real company and we will have meaningful earnings. No one seems to dispute the technology and I want to remind everyone here we are all invested for the same reason. We hold patents to a valuable link in diagnosing ALL TYPES of cancer and IMO will lead us to a link towards a cure. I have more faith in the technology by how fast we have come with the development of Recaf. Dr Moro has proven to me (I am speaking for myself) that he truly understands how to locate all cancer cells on a molecular level. It is difficult for the lay person to wrap their brain around such an accomplishment. I have turned positive when he said now it is time to let anyone at any level in science to test for themselves the level of sensitivity and specificity on ANY cancer for themselves. That is reassuring to me and my investment.
I don't think certain people on this board will ever be satisfied with Dr Moro until he pulls a baby out of a burning house.
Reread the press release. It says we are CURRENTLY DISCUSSING TERMS WITH INTERESTED PARTIES OVERSEAS.
I especially like this: Biocurex will keep its shareholders informed on future developments.
Everyone knows I have had my doubts in the past and have been very critical on management and their lack of communication. IMO, they are finally getting it right. I don't see Dr Moro ever giving up. He has surprised us all with the speed at which he has been able to convert from the RIA to chemoluminescent to the rapid test and now ELISA. To say he is not brilliant and truly convicted I would beg to differ. I see that Dr Moro has taken charge of the situation and he isn't taking s*** from anyone any longer. He knows what we have and he has serious plans to fully capitalize on it. Since he developed the ELISA it has become a game changer. We are not solely dependant on Inverness or Abbott any longer. I now look forward to each day knowing that we are truly part of something special.
Whoa, slow down Ted. There was alot of preparation and testing going on at Biocurex. For one, the reagants have to be shipped with a shelf life that would allow the labs to get accurate results and that means testing samples at one month, two months, three months, ect. so this ELISA test has been confirmed to be accurate for a period of time with consistency. Dr Moro says it is ready to go NOW!
He has ties in many countries outside the US and this new test is his answer to bypassing the FDA temporarily still keeping his eye on the big prize, but it will get us noticed and he opened the floodgates to anyone interested in the test. He is spelling it out to shareholders. He is ready. IMO we have already had discussions abroad and this is not something he just thought up this morning.
Your doubt is justified based on previous lack of communication by management, but now this is what we wanted so he says he developed a new test, he will be presenting at an upcoming INTERNATIONAL oncology conference, he has broadened our patents, he has added additional lab personel, he has been paying in cash, he has invited research centers, universities and labs to confirm his results, he told Abbott to pay up or hit the road. This is a true visionary and he has delivered over and over and it would not be prudent to bet against him. I don't see red flags I see green flags.
What do you think now Zolax? Can you say VINDICATION!
I can just see Inverness trying to calculate what our company is worth as they try and gobble up the 45 million outstanding shares. They have to take notice as to what was said and Dr Moro would never release his baby to the public till he had all his ducks in a row. He obviously feels great about the results and is putting his entire reputation as well as the scientific board members that represent Biocurex on the line. No more talking it is time to walk the walk. He even says this is a turning point for the company.
Dr Moro knows the true potential of Recaf and he is preparing to get the world ready. It will be a warm reception at upcoming meeting. I personally look forward to the day when I and my friends and family can have our blood tested for cancer and feel confident that I am cancer-free. The drug companies will need this test to monitor their patient's progress.
My guess is that we will be in Russia first because of Bhlokin, then China and Japan. We have close ties in both of these countries, and there have been studies on Recaf performed by scientists there. I like that he said we get upfront licensing payments and minimum sales quotas.
It sounds like we will be used in conjunction with today's tests as discussed by all of us.
Found an article when I googled Recaf June 2008
Sensitivity And Specificity - B000P6NTCU - Diana Mahoney An encouraging idea emerging from our study suggests that combining RECAF with CEA could greatly increase the overall sensitivity and specificity and that . ...
www.bioportfolio.com/bookshop/search/Sensitivity+And+Specificity
It must be an article that is published for sale, because it appears like a preview. It just goes to show us that there is alot going on behind closed doors. Longs don't panic we will see our reward. The technology will find its way into modern medicine. I am convinced after the ELISA we just removed the last road block.
Refresher course Recaf 101:
http://www.devicelink.com/ivdt/archive/05/06/004.html
Now fast forward 3 years and what Dr Moro has accomplished and the ways in which Recaf is now viable.
Dr Moro is expressing to shareholders that he has recently gained a significant amount knowledge on the intracacies of Recaf and NOW he is finally ready to show and challenge any other institution, research center, or scientist on the merits of his discovery.
Prior to the new patents and his commitment to perfect and reach optimal results, he wasn't ready to make such a bold statement. He has recently developed a "recipe" for a lack of a better word, that can show and duplicate our results. They will be questioned because they are in another league when compared to today's acceptable standards by doctors and insurance companies. It is unphathomable to the scientific community that there can actually be one "universal" marker and that is the challenge Dr Moro is facing. In the past, developing commercial ways to utilize the marker, collecting the data, and focusing on getting repeatable accurate results was the challenge.
Recently he stated that he is now pleased and comfortable with all the testing and now he will focus on commercialization. Things are much different from the last meeting. The hard part is over and when he has the opportunity in front of a live audience he will challenge them and allow them to test Recaf for themselves. He would have never done this prior to the new ELISA test, but he needed the patents in place to protect his discovery.
There will be much more interest when he presents the newest data and IMO he will finally get thru to the audience that this is not a fluke and they can now test it themselves. It will be exciting times from that day forward. It is like a beautiful painting. You wouldn't want to show it until you are satisfied with the last stroke of the brush.
Zolax
Zolax, we'll see if you are still gloating after the upcoming international oncology conference, but since you are not here to contribute I personally have blocked your childish commentary. Why you would wish to see this technology fail (which to the contrary has exceeded any diagnostic markers to date) is for your ego only. You certainly won't get a Nobel Prize for your contributions to science.
IF THE SILENCE SAYS EVERYTHING THEN YOU MUST BE SAYING NOTHING!
The market got pounded today, but not us. Thanks Dog, for not falling into their trap. It is easy to manipulate the share price because of the low volume.
Dr Moro is on the right track with the new ELISA test and should not wait for the meeting to make the offer to get Recaf into the hands of every institution so we can begin the process of converting the naysayers, and at the same time collect independent data for faster commercialization. Dr Moro please inform your shareholders when you have begun this process. It will be received as a major step forward and you will see your shareholders respond favorably.
Dog, it is a trap to cause the share price to go down. They made sure it closes at 50 cents, because there are 5000 shares for sale before we are back to 51 cents then 2500 to 53 cents. This is a pattern. Don't shoot yourself in the foot! If you buy 100 shares at market we all lose. That is their game and has been for quite some time. Let's end at 51 and call it a day.
Here we go like clockwork someone trying to push us lower at the open then sell lower at the close. Maybe we will get another block trade to push us higher or help us maintain a slight increase in share price. Dog, don't buy here it will only push us lower and help someone else. By keeping the share price low they are able to unjustly pick up cheap shares and I bet it is someone that is buying the big blocks at lower prices.
It would be a major endorsement if they just say that they have teamed up with Biocurex and anticipate trials or they are currently in trials. I have a bottle of champagne that really needs to uncorked.
The scientists at Biosite have to be pretty impressed that we now have the ELISA test and Dr Moro said he could technically begin commercialization outside the US with or without a licensee. Someone had left an order in at .44 since forever with a good till cancel order and just hit a major jackpot early this morning. There are definitely some larger block orders today. We can all hope we are on to something. I would love to end all of the controversy whether or not we will ever become commercialized and the sooner the better (it's been a long arduous road).
I am just reading off the press releases that said they are presenting at 10:30 June 12th at the New York Palace Hotel.
Inverness is doing a presentation next Thursday. The CEO and also the director have been doing a ton of insider buying this week. I wish it was because of us, but I'll settle for a mention of our company name at their biotech presentation next week. Obviously, they are upbeat and confident of what they are about to present and expect a rise in their share price.